Heart failure with mildly reduced or preserved ejection fraction
1 paper
- Human trial1
Latest
2 in 12 monthsCureus
Diabetes, Adiposity, and Functional Phenotypes in HFpEF: A Systematic Review of Recent Treatment-Response Evidence
Systematic review of randomised trialsInterventions
ADA Scientific Sessions 2026 Abstract
Emulation of a Trial of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
Study in peopleInterventions
Circulation Heart Failure
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
Randomised trial in 6,263 peopleDapagliflozin